Paliperidone Palmitate

Spezifikationen

199739-10-1CAS-Nummer

682-873-3EG-Nummer

[3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoateIUPAC-Name

C39H57FN4O4Chemische Formel

664.9 g/molMolekulargewicht

Paliperidone Palmitate; 199739-10-1; Invega Sustenna; xeplion; Invega Trinza; Ro 92670; RO92670; R8P8USM8FR; Ro-92670; ERZOFRI; JNS010; JNS-010; Hexadecanoic acid, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester; PALIPERIDONE JANSSEN; Hexadecanoic acid, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido(1,2-a)pyrimidin-9-yl ester; R-092670; (9RS)-3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidin-9-yl hexadecanoate; Sustenna, Invega; (9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl hexadecanoate; INVEGA HAFYERA; Palmitate, Paliperidone; Erzofri extended-release; RefChem:56593; CHEBI:83807; 9-Hydroxyrisperidone Palmitate; Paliperidone Palmitate [USAN]; 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl palmitate; MFCD24386477; Trinza; [3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate; 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl hexadecanoate; UNII-R8P8USM8FR; C39H57FN4O4; JNS 010; Hexadecanoic acid, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester; 9-Hydroxyrisperidone palmitate; Invega Sustenna; Paliperidone palmitate; RO 92670; PP3M; PALPERIDONE PALMITATE; orb1705887; SCHEMBL1871384; CHEMBL2107360; SCHEMBL12415674; CHEBI:83808; HY-A0019A; DTXSID70870217; GLXC-02551; PALIPERIDONE PALMITATE [MI]; EX-A9588; PALIPERIDONE PALMITATE [JAN]; s5624; PALIPERIDONE PALMITATE [VANDF]; AKOS030526057; PALIPERIDONE PALMITATE [MART.]; FP26726; PALIPERIDONE PALMITATE [WHO-DD]; SB17398; NCGC00522023-01; PALIPERIDONE PALMITATE [EMA EPAR]; AC-32485; AS-77089; DA-76562; PALIPERIDONE PALMITATE [ORANGE BOOK]; CS-0016387; D83646; T19950; R092670; Q27157250; [3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate; 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-ylpalmitate; 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl hexadecanoateSynonyme